Pliant Therapeutics Inc (PLRX)
11.81
-0.07
(-0.59%)
USD |
NASDAQ |
Apr 26, 16:00
11.81
0.00 (0.00%)
After-Hours: 20:00
Pliant Therapeutics Total Liabilities (Quarterly): 38.58M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.58M |
| September 30, 2023 | 37.42M |
| June 30, 2023 | 41.83M |
| March 31, 2023 | 35.96M |
| December 31, 2022 | 37.27M |
| September 30, 2022 | 40.19M |
| June 30, 2022 | 36.83M |
| March 31, 2022 | 23.23M |
| December 31, 2021 | 22.16M |
| Date | Value |
|---|---|
| September 30, 2021 | 13.68M |
| June 30, 2021 | 11.74M |
| March 31, 2021 | 11.08M |
| December 31, 2020 | 12.46M |
| September 30, 2020 | 11.98M |
| June 30, 2020 | 12.99M |
| March 31, 2020 | 10.50M |
| December 31, 2019 | 119.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.50M
Minimum
Mar 2020
119.50M
Maximum
Dec 2019
30.43M
Average
23.23M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Masimo Corp | 1.677B |
| Liquidia Corp | 71.04M |
| Vor Biopharma Inc | 47.40M |
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 512.15M |
| Shareholders Equity (Quarterly) | 473.58M |